Kenneth A. Lock

ARQT

Kenneth A. Lock serves as Chief Commercial Officer at Arcutis Biotherapeutics, Inc. (ARQT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$65.2K

Net Position

Net Seller

$65.2K

Companies Traded

ARQT

Active Period

Mar 2021 – Mar 2022

3 total trades

Most Recent

Sell ARQT

Mar 3, 2022 · $16.7K

Kenneth A. Lock's Insider Trading at Arcutis Biotherapeutics, Inc. (ARQT)

Buys

0 · $0.00

Sells

3 · $65.2K

Total Shares Bought

Total Shares Sold

2,861

ARQT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 3, 2022	Sell	993	$16.86	$16.7K
Mar 1, 2022	Sell	935	$17.75	$16.6K
Mar 1, 2021	Sell	933	$34.20	$31.9K

Related Insiders

Howard G. Welgus

Director

ARQTSell · Apr 3, 2026

Larry Todd Edwards

See Remarks

ARQTSell · Feb 4, 2026

Patrick Burnett

See Remarks

ARQTSell · Feb 4, 2026

Masaru Matsuda

See Remarks

ARQTSell · Feb 4, 2026

Latha Vairavan

SVP Chief Financial Officer

ARQTSell · Feb 4, 2026

Todd Watanabe

See Remarks

ARQTSell · Feb 4, 2026

LIN SUE-JEAN

Director

ARQTSell · Nov 24, 2025

Halley E Gilbert

Director

ARQTSell · Nov 20, 2025

Explore More Insider Trading Data

ARQT Insider Trading Activity

View all insider trades at Arcutis Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity